These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Plasma insulin and C-peptide levels in cirrhotic and uremic patients. Kawai K; Hayakawa H; Yoshida K; Shimizu M; Noto Y Diabete Metab; 1977 Mar; 3(1):7-10. PubMed ID: 323089 [TBL] [Abstract][Full Text] [Related]
3. Glucose intolerance in uremic patients: the relative contributions of impaired beta-cell function and insulin resistance. Alvestrand A; Mujagic M; Wajngot A; Efendic S Clin Nephrol; 1989 Apr; 31(4):175-83. PubMed ID: 2565775 [TBL] [Abstract][Full Text] [Related]
4. Impaired glucose tolerance and fasting hyperglycaemia have different characteristics. Davies MJ; Raymond NT; Day JL; Hales CN; Burden AC Diabet Med; 2000 Jun; 17(6):433-40. PubMed ID: 10975211 [TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of glucose intolerance in uremia. DeFronzo RA Metabolism; 1978 Dec; 27(12 Suppl 2):1866-80. PubMed ID: 723638 [TBL] [Abstract][Full Text] [Related]
6. The role of growth hormone in the glucose intolerance of uremia. DeFronzo RA; Tobin J; Boden G; Andres R Acta Diabetol Lat; 1979; 16(4):279-86. PubMed ID: 399149 [TBL] [Abstract][Full Text] [Related]
7. Glucose-induced insulin secretion in uremia: effects of aminophylline infusion and glucose loads. Allegra V; Mengozzi G; Martimbianco L; Vasile A Kidney Int; 1990 Dec; 38(6):1146-50. PubMed ID: 1963648 [TBL] [Abstract][Full Text] [Related]
8. Glucose intolerance in uremia. Quantification of pancreatic beta cell sensitivity to glucose and tissue sensitivity to insulin. DeFronzo RA; Tobin JD; Rowe JW; Andres R J Clin Invest; 1978 Aug; 62(2):425-35. PubMed ID: 353075 [TBL] [Abstract][Full Text] [Related]
9. Glucose intolerance in uremia (A- and B-cell function during conservative and dialytic management. Benedetti MM; Santeusanio F; Angeletti G; Filipponi P; Buoncristiani U; Brunetti P Acta Diabetol Lat; 1977; 14(5-6):235-49. PubMed ID: 613688 [TBL] [Abstract][Full Text] [Related]
10. Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM. 5-Year follow-up of initially nondiabetic Japanese-American men. Chen KW; Boyko EJ; Bergstrom RW; Leonetti DL; Newell-Morris L; Wahl PW; Fujimoto WY Diabetes Care; 1995 Jun; 18(6):747-53. PubMed ID: 7555498 [TBL] [Abstract][Full Text] [Related]
11. Assessment of beta-cell function during the oral glucose tolerance test by a minimal model of insulin secretion. Cretti A; Lehtovirta M; Bonora E; Brunato B; Zenti MG; Tosi F; Caputo M; Caruso B; Groop LC; Muggeo M; Bonadonna RC Eur J Clin Invest; 2001 May; 31(5):405-16. PubMed ID: 11380592 [TBL] [Abstract][Full Text] [Related]
12. [Pancreatic B cell function and glucose intolerance in the elderly]. Nozaki T Nihon Ika Daigaku Zasshi; 1989 Apr; 56(2):153-65. PubMed ID: 2659622 [TBL] [Abstract][Full Text] [Related]
13. Effect of dialysis treatment on glucose metabolism in uremic patients. Kaneda H; Mimura N Tohoku J Exp Med; 1977 May; 122(1):35-42. PubMed ID: 918954 [TBL] [Abstract][Full Text] [Related]
14. Insulin response to oral glucose load is consistently decreased in established non-insulin-dependent diabetes mellitus: the usefulness of decreased early insulin response as a predictor of non-insulin-dependent diabetes mellitus. Kosaka K; Kuzuya T; Hagura R; Yoshinaga H Diabet Med; 1996 Sep; 13(9 Suppl 6):S109-19. PubMed ID: 8894494 [TBL] [Abstract][Full Text] [Related]
15. [Analysis of islet B cell reserve in patients with NIDDM]. Sun Q Zhonghua Yi Xue Za Zhi; 1989 Apr; 69(4):198-9, 16. PubMed ID: 2673493 [TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of age-related glucose intolerance in man: insulin resistance and decreased beta-cell function. Chen M; Bergman RN; Pacini G; Porte D J Clin Endocrinol Metab; 1985 Jan; 60(1):13-20. PubMed ID: 3880560 [TBL] [Abstract][Full Text] [Related]
17. Study of genetic prediabetic south Indian subjects. Importance of hyperinsulinemia and beta-cell dysfunction. Snehalatha C; Ramachandran A; Satyavani K; Latha E; Viswanathan V Diabetes Care; 1998 Jan; 21(1):76-9. PubMed ID: 9538973 [TBL] [Abstract][Full Text] [Related]
18. Somatostatin release in response to glucose is impaired in chronic renal failure. Franceschini R; Robaudo C; Corsini G; Cataldi A; Bruno E; Russo R; Rolandi E; Barreca T Biomed Pharmacother; 1998; 52(5):208-13. PubMed ID: 9755817 [TBL] [Abstract][Full Text] [Related]
19. Comparison of three methods for the quantification of beta-cell function and insulin sensitivity. Nijpels G; van der Wal PS; Bouter LM; Heine RJ Diabetes Res Clin Pract; 1994 Dec; 26(3):189-95. PubMed ID: 7736899 [TBL] [Abstract][Full Text] [Related]
20. beta-cell function and glucose and lipid oxidation in Graves' disease. Bech K; Damsbo P; Eldrup E; Beck-Nielsen H; Røder ME; Hartling SG; Vølund A; Madsbad S Clin Endocrinol (Oxf); 1996 Jan; 44(1):59-66. PubMed ID: 8706294 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]